| Date | Form | Description | Docs | XBRL | Pages |
| 01/26/12 | 5 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 01/18/12 | CT ORDER | Confidential treatment order |
|
1 | |
| 11/30/11 | 10-Q/A | Quarterly report pursuant to sections 13 or 15(d) |
|
36 | |
| 11/03/11 | 8-K | Current report filing |
|
3 | |
| 10/31/11 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/14/11 | 10-Q/A | Quarterly report pursuant to sections 13 or 15(d) |
|
|
3 |
| 09/23/11 | DEF 14A | Definitive proxy statements |
|
22 | |
| 09/14/11 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
79 | |
| 07/07/11 | S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans |
|
32 | |
| 07/07/11 | 8-K | Current report filing |
|
5 |
Latest News & Events
Anixa Biosciences Secures United States Adopted Names Council Approval of Non-Proprietary Name for its CAR-T Therapy, a Key Step Toward Future Commercialization
Read More...Anixa Biosciences Receives Notice of Allowance from Mexican Institute of Industrial Property (IMPI) for Patent Covering Breast Cancer Vaccine Technology
Read More...Anixa Biosciences Announces Transfer of IND for Breast Cancer Vaccine from Cleveland Clinic
Read More...